Tag: contraceptives market outlook

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Contraceptives Market Size Forecast: How Big Could The Market Get By 2030?

The contraceptives market size has demonstrated significant expansion in recent years. It is projected to expand from $29.74 billion in 2025 to $32.02 billion in 2026, driven by a compound annual growth rate (CAGR) of 7.7%. The observed growth in previous periods can be linked to factors such as government-led family planning programs, improved access to oral contraceptive pills, an increase in urban female workforce participation, public health campaigns aimed at population control, and the expansion of contraceptive services offered by hospitals and clinics.

The contraceptives market is projected to experience substantial growth in the upcoming years. It is anticipated to reach $43.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period is fueled by several factors, including advancements in non-hormonal and male contraceptive innovations, the increasing reach of online pharmacies, heightened reproductive health awareness among adolescents, continuous technological progress in implantable devices, and favorable regulatory approvals for new contraceptives. Key trends expected in this period encompass a rise in the adoption of long-acting reversible contraceptives, a growing inclination towards non-hormonal contraceptive choices, an increased demand for female-controlled birth control methods, the wider availability of over-the-counter and self-administered products, and an intensified focus on contraceptive education for adolescents and young adults.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=39730992&type=smp&name=Contraceptives%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Contraceptives Market Growth Factors: What’s Supporting Expansion?

The worldwide increase in population rates is projected to stimulate the growth of the contraceptive market in the upcoming years. Population denotes the overall number of individuals, species, or people residing within a particular geographic region, country, or the entire world. Contraceptives play a crucial role in reducing population by allowing couples and individuals to manage and plan their family size and the spacing of their children. As an illustration, in December 2024, according to the United States Census Bureau, a US-based federal agency, the U.S. population reached 340.1 million as of July 1, 2024, which indicated a 0.98% increase from 336.8 million in 2023, marking the highest annual growth rate recorded. Therefore, the global rise in population rates is significantly driving the contraceptive market.

Contraceptives Market Segment Outlook: Which Categories Are Growing Fastest?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

Contraceptives Market Industry Trends: What’s Reshaping Demand?

Leading firms in the contraceptives sector are prioritizing new products, including Opill, progestin-only daily oral contraceptives, to more effectively address the demands of their current user base. Frequently referred to as the mini-pill, Opill progestin-only daily oral contraceptives are a contraceptive pill type containing solely progestin, which is a synthesized form of the hormone progesterone. An example of this is when, in July 2023, Perrigo Company plc, an Ireland-based manufacturer of over-the-counter pharmaceuticals, declared that the U. S. Food and Drug Administration (FDA) had approved Opill progestin-only daily oral contraceptives. In the United States, Opill marks the inaugural birth control pill accessible without a prescription. This product has the potential to considerably enhance women’s access to contraceptives and stands as a true reflection of Perrigo’s ongoing commitment to providing impactful solutions that positively affect individuals’ lives.

Contraceptives Market Leading Companies And Competitive Benchmarking

Major companies operating in the contraceptives market are Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

View The Full Contraceptives Market Report:

https://thebusinessresearchcompany.com/report/contraceptives-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Contraceptives Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Contraceptives Market Revenue Growth Supported By A CAGR Of 43.08% Through 2030

The market for contraceptives has experienced robust expansion in recent years, with projections indicating an increase from $29.74 billion in 2025 to $32.02 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.7%. This historical growth has been driven by factors such as government-sponsored family planning programs, greater accessibility to oral contraceptive pills, a growing number of women joining the urban workforce, public health efforts aimed at population management, and the broader availability of contraceptive services through hospitals and clinics.

The contraceptive market is anticipated to experience robust expansion in the coming years, projected to reach a valuation of $43.09 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.7%. This upward trajectory in the forecast period is driven by several key factors, including breakthroughs in non-hormonal and male contraceptive development, a growing presence of online pharmacies, heightened reproductive health education among younger populations, progress in implantable device technology, and favorable regulatory support for new contraceptive products. Significant trends shaping this period involve a growing preference for long-acting reversible contraceptives, a shift toward non-hormonal options, a heightened demand for female-controlled methods, an increase in over-the-counter and self-administered offerings, and a concentrated effort to improve contraceptive awareness among adolescents and young adults.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Contraceptives Market Growth Momentum: Which Factors Are Influencing Demand?

The anticipated expansion of the global contraceptive market in the years ahead is being driven by increasing population rates worldwide. Population is defined as the total count of individuals, species, or people inhabiting a specific geographic area, a country, or the entire globe. By enabling individuals and couples to manage and plan their family size and the timing of children, contraceptives play a crucial role in slowing population growth. For example, in December 2024, the United States Census Bureau—a federal agency based in the US—reported that the U.S. population had climbed to 340.1 million as of July 1, 2024. This marks a 0.98% rise from 336.8 million in 2023, representing the highest annual growth rate ever recorded. Consequently, the upward trend in global population rates is fueling demand within the contraceptive market.

Contraceptives Market Segmentation And Category Breakdown

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

Contraceptives Market Trends Reshaping Industry Growth

Key players in the contraceptives industry are placing a strong emphasis on developing groundbreaking products, including Opill, a progestin-only daily oral contraceptive, designed to more effectively address the requirements of their current customer base. These progestin-only daily oral contraceptives, commonly referred to as the mini-pill, represent a type of birth control pill that exclusively contains progestin, a synthetic form of the hormone progesterone. A notable example occurred in July 2023, when Perrigo Company plc, an Ireland-based manufacturer specializing in over-the-counter pharmaceuticals, secured approval from the U.S. Food and Drug Administration (FDA) for its Opill progestin-only daily oral contraceptive. This marks the first birth control pill ever made accessible without a prescription in the United States. By significantly enhancing women’s access to contraceptives, Opill stands as a clear reflection of Perrigo’s unwavering commitment to providing impactful solutions that aim to enhance quality of life.

Contraceptives Market Competitive Analysis Of Major Industry Participants

Major companies operating in the contraceptives market are Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Access The Complete Contraceptives Market Report:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Contraceptives Market Geographic Distribution And Regional Opportunities

North America was the largest region in the contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Expansion Is Expected For The Contraceptives Market Over The Forecast Period?

The contraceptives market has experienced significant expansion recently. Growth is expected to take the market from $29.74 billion in 2025 to $32.02 billion in 2026, at a compound annual growth rate (CAGR) of 7.7%. Historically, this growth was driven by factors such as government-led family planning programs, enhanced access to oral contraceptive pills, an increase in urban female workforce participation, public health campaigns focusing on population control, and the expansion of contraceptive services provided in hospitals and clinics.

The contraceptives market size is anticipated to experience substantial growth in the coming years. It is projected to reach $43.09 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period can be attributed to various factors, including the development of non-hormonal and male contraceptive innovations, increasing prevalence of online pharmacies, rising reproductive health awareness among adolescents, technological progress in implantable devices, and supportive regulatory approvals for new contraceptive products. Prominent trends for the forecast period include the increasing adoption of long-acting reversible contraceptives, a growing preference for non-hormonal contraceptive options, rising demand for female-controlled contraceptive methods, the expansion of over-the-counter and self-administered products, and an increased emphasis on adolescent and young adult contraceptive awareness.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

Which Major Factors Are Contributing To The Development Of The Contraceptives Market?

An increase in global population is projected to fuel the expansion of the contraceptive market in the foreseeable future. Population denotes the total count of individuals, species, or inhabitants residing within a specific geographic area, nation, or the world. Contraceptives are instrumental in managing population levels by enabling couples and individuals to control their family size and space out births. For example, in December 2024, the United States Census Bureau, a federal agency based in the US, reported that the U.S. population hit 340.1 million by July 1, 2024. This represented a 0.98% rise from 336.8 million in 2023, marking the highest recorded annual growth rate. Consequently, the worldwide increase in population rates is a key driver for the contraceptive market.

What Segment Types Are Included In The Contraceptives Market Analysis?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

Which Trends Are Affecting The Contraceptives Market Framework?

Leading companies in the contraceptives market are concentrating on innovative offerings, such as Opill, a progestin-only daily oral contraceptive, to better address the needs of their existing consumer base. Opill progestin-only daily oral contraceptives, often recognized as the mini-pill, are a type of birth control pill that contains only progestin, a synthetic form of the hormone progesterone. For example, in July 2023, Perrigo Company plc, an Ireland-based manufacturer of over-the-counter pharmaceuticals, announced U.S. Food and Drug Administration (FDA) approval for Opill progestin-only daily oral contraceptives. Opill stands as the first birth control pill to be available in the United States without a prescription. Opill has the capacity to significantly enhance women’s access to contraceptives and genuinely reflects Perrigo’s ongoing dedication to providing impactful solutions that improve people’s lives.

Who Are The Major Companies Operating In The Contraceptives Market?

Major companies operating in the contraceptives market are Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Access The Complete Contraceptives Market Report:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

What Is The Largest Regional Market In The Contraceptives Market?

North America was the largest region in the contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Contraceptives Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

Browse Through More Reports Similar to the Global Contraceptives Market 2026, By The Business Research Company

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Contraceptives Market Expected To Reach Based On Its 2026 Value?

The contraceptives market size has experienced significant expansion in recent years. This market is anticipated to climb from $29.74 billion in 2025 to $32.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.7%. The historical progression can be linked to government-driven family planning programs, enhanced accessibility of oral contraceptive pills, an increase in urban female workforce participation, public health initiatives focusing on population management, and the broadened scope of contraceptive services available at hospitals and clinics.

The contraceptives market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $43.09 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This anticipated growth throughout the forecast period stems from factors such as advancements in non-hormonal and male contraceptive innovations, the expanding reach of online pharmacies, heightened reproductive health awareness among adolescents, technological progress in implantable devices, and favorable regulatory endorsements for new contraceptive methods. Key trends identified for the forecast period encompass an uptick in the adoption of long-acting reversible contraceptives, a growing inclination towards non-hormonal contraceptive choices, an escalating demand for female-controlled birth control methods, the broadening availability of over-the-counter and self-administered products, and a heightened emphasis on contraceptive awareness among adolescents and young adults.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

What Key Factors Are Affecting The Contraceptives Market Demand?

The increasing global population is anticipated to boost the expansion of the contraceptive market in the foreseeable future. Population defines the total count of individuals, species, or humans residing within a specific geographical area, nation, or worldwide. Contraceptive methods are crucial in managing population levels by enabling individuals and couples to control family size and the timing of births. For example, the United States Census Bureau, a federal agency based in the US, reported in December 2024 that the U.S. population hit 340.1 million by July 1, 2024. This represented a 0.98% rise from 336.8 million in 2023, marking the highest recorded annual growth rate. Consequently, the worldwide increase in population rates is a key driver for the contraceptive market.

How Is The Contraceptives Market Organized By Segment Classification?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

Which Trends Are Impacting The Progress Of The Contraceptives Market?

Leading firms within the contraceptives market are concentrating on novel offerings, including Opill, a progestin-only daily oral contraceptive, to more effectively satisfy the requirements of their current customer base. These Opill progestin-only daily oral contraceptives, frequently referred to as the mini-pill, constitute a form of birth control containing solely progestin, which is a synthetic form of the hormone progesterone. An example of this is Perrigo Company plc, an Ireland-based manufacturer of over-the-counter pharmaceuticals, which announced U. S. Food and Drug Administration (FDA) approval for Opill progestin-only daily oral contraceptives in July 2023. Notably, Opill marks the inaugural birth control pill accessible without a prescription throughout the United States. This product is poised to substantially enhance the accessibility of contraceptives for women and truly demonstrates Perrigo’s unwavering commitment to providing significant solutions that better people’s lives.

Who Are The Industry Participants Involved In The Contraceptives Market?

Major companies operating in the contraceptives market are Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Get The Full Contraceptives Market Report:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Which Region Has The Greatest Market Share In The Contraceptives Market?

North America was the largest region in the contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Contraceptives Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Browse Through More Reports Similar to the Global Contraceptives Market 2026, By The Business Research Company

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Contraceptives Market From 2026 To 2030?

The contraceptives market has demonstrated substantial growth in recent years. It is projected to increase from $29.74 billion in 2025 to $32.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.7%. This historical expansion can be attributed to factors such as government-led family planning initiatives, enhanced availability of oral contraceptive pills, increasing urban female workforce participation, public health campaigns focused on population control, and the broadened provision of hospital and clinic-based contraceptive services.

The contraceptives market is projected to experience substantial expansion in the coming years. By 2030, its value is forecast to reach $43.09 billion, exhibiting a compound annual growth rate (CAGR) of 7.7%. This growth in the forecast period is attributable to several factors, including advancements in non-hormonal and male contraceptive innovation, increased accessibility through online pharmacies, heightened reproductive health awareness among adolescents, technological progress in implantable devices, and supportive regulatory approvals for novel contraceptives. Key trends anticipated during this period encompass a rising adoption of long-acting reversible contraceptives, an increasing preference for non-hormonal contraceptive options, a growing demand for female-controlled contraceptive methods, the expansion of over-the-counter and self-administered products, and an intensified focus on adolescent and young adult contraceptive awareness.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

What Major Drivers Are Influencing Demand In The Contraceptives Market?

The increasing global population is projected to stimulate expansion in the contraceptive market over the next few years. Population signifies the total count of beings, species, or humans inhabiting a specific geographical area, nation, or the world as a whole. Contraceptives are instrumental in reducing population growth by enabling couples and individuals to manage their family size and space out births. As an illustration, in December 2024, the United States Census Bureau, a US-based federal agency, reported that the U.S. population hit 340.1 million by July 1, 2024. This represented a 0.98% rise from 336.8 million in 2023, marking the highest annual growth rate on record. Consequently, the worldwide increase in population rates is a key driver for the contraceptive market.

Which Segments Are Included In The Analysis Of The Contraceptives Market?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

Which Trends Are Impacting The Growth Of The Contraceptives Market?

Major companies in the contraceptives market are concentrating on developing innovative products, such as Opill, a progestin-only daily oral contraceptive, to better serve the requirements of their current consumers. Opill progestin-only daily oral contraceptives, frequently called the mini-pill, are a type of birth control pill containing solely progestin, a synthetic form of the hormone progesterone. For example, in July 2023, Perrigo Company plc, an Ireland-based producer of over-the-counter pharmaceuticals, announced the U. S. Food and Drug Administration (FDA) approval for Opill progestin-only daily oral contraceptives. Opill stands as the first birth control pill to be available without a prescription in the United States. Opill is expected to substantially enhance women’s access to contraceptives and truly reflects Perrigo’s consistent dedication to offering significant solutions that enhance people’s lives.

Which Key Industry Participants Are Active In The Contraceptives Market?

Major companies operating in the contraceptives market are Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Read the full contraceptives market report here:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Contraceptives Market?

North America was the largest region in the contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Contraceptives Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6920&type=smp

Browse Through More Reports Similar to the Global Contraceptives Market 2026, By The Business Research Company

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the contraceptives market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Contraceptives Market?

The contraceptives market size has experienced strong growth in recent years. It is projected to expand from $29.74 billion in 2025 to $32.02 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.7%. The historical growth can be attributed to government-led family planning initiatives, enhanced availability of oral contraceptive pills, increasing urban female workforce participation, public health campaigns on population control, and the expansion of hospital and clinic-based contraceptive services.

The contraceptives market size is anticipated to experience robust expansion in the coming years. It is projected to reach $43.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This growth over the forecast period is attributable to several factors, including advancements in non-hormonal and male contraceptive innovation, increased penetration of online pharmacies, a rise in reproductive health awareness among adolescents, technological advancements in implantable devices, and supportive regulatory approvals for novel contraceptives. Furthermore, key trends in this period are expected to involve a rising adoption of long-acting reversible contraceptives, an increasing preference for non-hormonal contraceptive options, a growing demand for female-controlled contraceptive methods, an expansion of over-the-counter and self-administered products, and an increasing focus on adolescent and young adult contraceptive awareness.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

What Drivers Are Supporting Technological Adoption In The Contraceptives Market?

An increase in global population rates is anticipated to drive the expansion of the contraceptive market over the next few years. Population is defined as the total count of individuals, species, or humans inhabiting a specific geographical area, nation, or the world. Contraceptives are crucial in mitigating population growth by enabling couples and individuals to manage their family size and space out births. To illustrate, data from December 2024, provided by the United States Census Bureau, a federal agency based in the US, indicated that the U.S. population reached 340.1 million by July 1, 2024. This represented a 0.98% rise from 336.8 million in 2023, marking the highest annual growth rate documented. Consequently, the worldwide increase in population rates is a key driver for the contraceptive market.

What Segment Types Are Examined In The Contraceptives Market?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

Which Trends Are Influencing The Performance And Direction Of The Contraceptives Market?

Leading companies in the contraceptives market are prioritizing innovative products, such as Opill, which are progestin-only daily oral contraceptives, to better address the needs of their existing customer base. Opill progestin-only daily oral contraceptives, often recognized as the mini-pill, constitute a form of birth control pill containing solely progestin, a synthetic variant of the hormone progesterone. For instance, in July 2023, Perrigo Company plc, an Ireland-based manufacturing entity specializing in over-the-counter pharmaceuticals, announced the U. S. Food and Drug Administration (FDA) approval for Opill progestin-only daily oral contraceptives. Opill stands as the inaugural birth control pill available in the United States without requiring a prescription. This product can significantly enhance the availability of contraceptives for women and serves as a genuine reflection of Perrigo’s ongoing commitment to providing impactful solutions that improve people’s lives.

Who Are The Major Companies Operating In The Contraceptives Market?

Major companies operating in the contraceptives market are Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Contraceptives Market?

North America was the largest region in the contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Contraceptives Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6920&type=smp

Browse Through More Reports Similar to the Global Contraceptives Market 2026, By The Business Research Company

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the contraceptives market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Contraceptives Market By The End Of 2029?

The contraceptives market has demonstrated substantial growth in recent years. It is projected to expand from $27.92 billion in 2024 to $29.74 billion in 2025, at a compound annual growth rate (CAGR) of 6.5%. Historically, this growth can be ascribed to several factors, including the introduction of the birth control pill, enhanced awareness and education surrounding contraception, legal and social advancements that promote reproductive rights, global efforts in population control, and a surge in the utilization of generic and low-cost drugs and devices.

The contraceptives market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach “$40 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.7%. This anticipated growth during the forecast period stems from factors such as an increasing emphasis on male contraceptives, enhanced availability of contraception in developing nations, the incorporation of digital health technologies in contraception, a heightened need for long-acting reversible contraceptives (LARCS), and easier accessibility to over-the-counter drugs on the online platform. Key trends for the forecast period encompass technological advancements in contraceptive methods, a move towards non-hormonal and natural contraceptive methods, broadened over-the-counter access to certain contraceptives, a focus on user-friendly and discreet contraceptive options, and the integration of telemedicine in contraceptive counseling and prescriptions.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

Which Business Drivers Are Underpinning The Growth Of The Contraceptives Market?

The increasing incidence of sexually transmitted illnesses or diseases is fueling the demand for contraceptives. Sexually transmitted diseases (STDs) are infections transmitted from one individual to another through sexual interaction. The most common forms of contact involve anal, oral, and vaginal intercourse, though they can also spread via other close physical contact methods. Contraceptives are utilized to manage the transmission of sexually transmitted diseases like herpes and HPV, which primarily spread through skin-to-skin contact. For instance, in May 2023, according to the Minnesota Department of Health, a US-based state health agency of the State of Minnesota, primary and secondary syphilis cases rose by 19% in 2022, from 564 in 2021 to 676 in 2022. In 2022, 20 instances of congenital syphilis in babies were recorded, which represents a 42 % increase from 2021, when 14 cases of congenital syphilis were documented. Therefore, the increase in sexually transmitted illnesses or diseases is projected to boost the demand for contraceptives during the forecast period.

What Are The Principal Segment Types In The Contraceptives Market?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

How Are Industry Trends Steering The Expansion Of The Contraceptives Market?

Leading companies in the contraceptives market are concentrating on developing innovative contraceptive solutions, including the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptives, to enhance user convenience, increase effectiveness, and provide long-term birth control options. These advancements aim to reduce the need for frequent dosing, improve accessibility, and minimize side effects, thereby offering more reliable and discreet contraceptive solutions for individuals seeking better reproductive health management. For instance, in October 2023, the Health and Family Welfare Ministry, an India-based government agency, introduced two new methods, the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive, with the goal of improving family planning services. These methods are part of the National Family Planning Programme and are designed to enhance maternal and infant health outcomes. The introduction of these contraceptives seeks to decrease maternal and infant morbidity and mortality rates by providing a wider range of options for family planning. This initiative reflects a broader strategy to bolster reproductive health services in Karnataka, ensuring that women have access to safe and effective contraceptive methods.

Which Companies Are Contributing Significantly To The Contraceptives Market Growth?

Major companies operating in the contraceptives market include Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Which Region Offers The Most Opportunity For Contraceptives Market Expansion?

North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=6920&type=smp

Browse Through More Reports Similar to the Global Contraceptives Market 2025, By The Business Research Company

Hormonal Contraceptives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Polycystic Ovarian Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

Genito Urinary Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Contraceptives Market Between 2025 And 2029?

The contraceptives market has experienced robust expansion over recent years. Projections indicate its value will rise from $27.92 billion in 2024 to $29.74 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 6.5%. This historical expansion is primarily due to factors such as the advent of the birth control pill, heightened awareness and educational efforts regarding contraception, legislative and societal shifts advocating for reproductive rights, worldwide population management programs, and the rising adoption of generic and affordable drugs and devices.

The contraceptives market is anticipated to show robust expansion over the next few years, with its valuation expected to reach $40 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.7%. This projected increase is fueled by factors such as an intensified focus on male contraceptives, improved access to birth control in emerging economies, the integration of digital health technologies within contraception, a rising demand for long-acting reversible contraceptives (LARCS), and enhanced availability of over-the-counter drugs through online platforms. Significant trends foreseen in this forecast period encompass technological progress in contraceptive approaches, a move towards non-hormonal and natural methods, the broadening of over-the-counter access for specific contraceptives, a prioritization of user-friendly and discreet options, and the incorporation of telemedicine into contraceptive counseling and prescription services.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

Which Drivers Are Impacting The Contraceptives Market?

The increasing incidence of sexually transmitted diseases (STDs) is fueling the need for contraceptives. STDs refer to infections transmitted between individuals via sexual contact. While most commonly spread through anal, oral, and vaginal intercourse, they can also be transmitted via other forms of close physical contact. Contraceptives are utilized to help control the spread of STDs such as herpes and HPV, which often transmit through skin-to-skin contact. For example, in May 2023, data from the Minnesota Department of Health, a US-based state health agency, revealed that primary and secondary syphilis cases rose by 19% in 2022, increasing from 564 in 2021 to 676 in 2022. Furthermore, 20 instances of congenital syphilis in infants were reported in 2022. This marked a 42% increase from the 14 cases of congenital syphilis documented in 2021. Consequently, the growing prevalence of sexually transmitted diseases is projected to escalate the demand for contraceptives throughout the forecast period.

How Is The Contraceptives Market Classified Into Different Segments?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

Which Ongoing Trends Are Expected To Shape The Contraceptives Market Outlook?

Leading companies in the contraceptives market are concentrating on developing innovative birth control methods, such as the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptives, to improve user convenience, boost effectiveness, and offer long-term birth control solutions. These advancements aim to decrease the need for frequent dosing, enhance accessibility, and minimize side effects, thereby providing more dependable and discreet contraceptive options for individuals seeking better reproductive health management. For instance, in October 2023, the Health and Family Welfare Ministry, an India-based government agency, introduced two new methods, the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive, intended to enhance family planning services. These methods are integrated into the National Family Planning Programme and are designed to improve maternal and infant health outcomes. The introduction of these contraceptives seeks to reduce maternal and infant morbidity and mortality rates by expanding family planning choices. This initiative reflects a broader strategy to upgrade reproductive health services in Karnataka, ensuring that women have access to safe and effective contraceptive methods.

Who Are The Core Companies Influencing The Contraceptives Market Landscape?

Major companies operating in the contraceptives market include Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

What Are The Key Regional Factors Influencing The Contraceptives Market Growth?

North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Contraceptives Market Report:

https://www.thebusinessresearchcompany.com/customise?id=6920&type=smp

Browse Through More Reports Similar to the Global Contraceptives Market 2025, By The Business Research Company

Hormonal Contraceptives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Polycystic Ovarian Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

Genito Urinary Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Contraceptives Market?

The size of the contraceptives market has experienced robust growth in the recent past. The market, which was valued at $27.92 billion in 2024, is projected to increase to $29.74 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.5%. Factors such as the introduction of birth control pills, heightened awareness and education pertaining to contraception, legislative and societal shifts favouring reproductive rights, worldwide population control measures, and a rise in the usage of generic and affordable drugs and devices have contributed to the growth experienced during the historic period.

In the next few years, the contraceptives market is anticipated to experience robust growth. It is projected to expand to “$40 billion by 2029, with a compound annual growth rate (CAGR) of 7.7%. This impending growth during the forecast period can be linked to the increasing interest in male contraceptives, improved access to contraception in developing nations, the integration of digital health technology in contraception, a surge in demand for long-acting reversible contraceptives (LARCS), and growing ease of access to over-the-counter drugs via online platforms. Key trends in the forecast period encompass technological innovations in contraceptive techniques, a shift towards non-hormonal and natural contraceptive methods, broader over-the-counter access to certain contraceptives, focus on user-friendly and discreet contraceptive options, and the inclusion of telemedicine in contraceptive advice and prescriptions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

What Core Drivers Are Expected To Influence The Contraceptives Market?

The growing prevalence of sexually transmitted diseases (STDs) is fuelling the need for contraceptives. STDs are disorders that are transmitted from one individual to another through sexual interaction. They are most commonly spread during anal, vaginal, and oral intercourse, but they can also be transmitted through other close physical contact methods. Contraceptives are used primarily to prevent the transmission of STDs such as herpes and HPV, which are typically transmitted through skin-to-skin contact. For instance, as per the Minnesota Department of Health, a state health agency in the US, the number of primary and secondary syphilis cases rose to 676 in 2022, a 19% increase from 564 in 2021. Similarly, in 2022, 20 cases of newborns with congenital syphilis were reported, reflecting a 42% increase from the previous year, when 14 cases were recorded. Thus, the increase in sexually transmitted diseases or infections is anticipated to heighten the demand for contraceptives in the near future.

What Are The Main Segment Classifications In The Contraceptives Market?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

How Are Industry Trends Steering The Expansion Of The Contraceptives Market?

Leading firms in the contraceptives market are striving to create innovative methods such as the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptives. The goal is to improve user convenience, boost efficacy, and offer long-term birth control choices, diminishing the necessity for regular dosing, enhancing availability, and lessening side effects. These advancements contribute to the creation of more dependable and discreet birth control methods for those wanting improved reproductive health management. For example, in October 2023, the Health and Family Welfare Ministry, a government organization based in India, introduced two new techniques, the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive, with the aim to augment family planning services. These approaches form part of the National Family Planning Programme, designed with the aim of improving the health outcomes of mothers and infants. The goal of these birth control methods is to decrease mother and infant morbidity and mortality rates by expanding the choices for family planning. This initiative falls under a wider strategy to improve reproductive health services in Karnataka, ensuring women can access safe and effective contraceptive techniques.

Which Companies Are Contributing Significantly To The Contraceptives Market Growth?

Major companies operating in the contraceptives market include Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Which Region Holds The Greatest Opportunity For Contraceptives Market Expansion?

North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=6920&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model